HSD118 Real-World Treatment Patterns and Cardiovascular Disease (CVD) Burden in Patients With Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) Receiving Covalent Bruton’s Tyrosine Kinase Inhibitors (cBTKis)
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.2397
https://www.valueinhealthjournal.com/article/S1098-3015(24)02611-1/fulltext
Title :
HSD118 Real-World Treatment Patterns and Cardiovascular Disease (CVD) Burden in Patients With Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) Receiving Covalent Bruton’s Tyrosine Kinase Inhibitors (cBTKis)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)02611-1&doi=10.1016/j.jval.2024.03.2397
First page :
Section Title :
Open access? :
No
Section Order :
10729